41 studies found for:    Open Studies | "Goiter"
Show Display Options
Rank Status Study
21 Not yet recruiting Next-generation Sequencing (NGS) of Peripheral Blood Immune Repertoire in Graves' Disease
Condition: Graves Disease
Intervention:
22 Recruiting Selenium Supplementation Versus Placebo in Patients With Graves' Hyperthyroidism
Condition: Graves' Hyperthyroidism
Interventions: Dietary Supplement: Selenium;   Other: Placebo
23 Recruiting Bupivacaine Injection of Eye Muscles to Treat Strabismus
Conditions: Strabismus;   Esotropia;   Exotropia;   Graves Disease;   Nystagmus
Intervention: Drug: Bupivacaine
24 Recruiting Comparison Study Between Two Techniques for Correction of Upper Lid Retraction in Patients With Grave's Orbitopathy
Condition: Graves Ophthalmopathy
Interventions: Procedure: blepharotomy;   Procedure: posterior approach
25 Not yet recruiting Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease
Condition: Graves Ophthalmopathy
Interventions: Radiation: External beam radiotherapy;   Drug: intravenous corticosteroids (methylprednisolone)
26 Unknown  The Effect of Early Total Thyroidectomy in the Course of Graves' Orbitopathy
Condition: Graves' Ophthalmopathy
Interventions: Procedure: Total Thyroidectomy;   Drug: Propylthiouracil
27 Recruiting Comparative Study of Different I-131 Doses in Graves' Disease
Condition: Graves' Disease
Interventions: Drug: Low dose of I-131;   Drug: Intermediate dose;   Drug: High dose
28 Recruiting A Prospective, Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' Orbitopathy
Condition: Graves' Ophthalmopathy
Intervention: Drug: methylprednisolone, prednisone
29 Not yet recruiting Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues
Condition: Thyroid Associated Ophthalmopathies
Intervention: Drug: bimatoprost 0.03%
30 Recruiting Radioactive Iodide Therapy for Pediatric Graves' Disease
Condition: Graves' Disease
Interventions: Radiation: RAI treatment;   Drug: ATD Group
31 Recruiting Teprotumumab Treatment in Patients With Active Thyroid Eye Disease
Conditions: Thyroid Associated Ophthalmopathies;   Thyroid-Associated Ophthalmopathy
Interventions: Drug: teprotumumab;   Drug: Placebo
32 Unknown  Effect of Percutaneous Botulinum Toxin A Injection on Natural Course of Upper Lid Retraction in Thyroid Eye Disease
Condition: Eye Diseases
Intervention: Drug: Botulinum toxin A injection
33 Recruiting Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease
Condition: Thyroid Eye Disease
Interventions: Drug: Hyaluronic Acid Gel injection;   Drug: Saline injection
34 Recruiting Selenium in Mild Thyroid Eye Disease in North America
Condition: Thyroid Associated Ophthalmopathies
Interventions: Dietary Supplement: Sodium selenite;   Dietary Supplement: Sugar pill
35 Recruiting mDixon TSE MRI Sequence And Conventional MRI Sequences In Dysimmune Orbitopathies (DDX)
Condition: Dysthyroid Ophthalmopathies
Intervention:
36 Not yet recruiting The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.
Conditions: Thyroid Eye Disease;   Ocular Hypertension;   Glaucoma
Interventions: Drug: Prostaglandin Analog;   Drug: Timolol
37 Unknown  The Role of TSH Receptor, PPAR-r, IGF-1R, IGF and Cytokines in Different Stages of Graves’Ophthalmopathy
Condition: Graves' Ophthalmopathy
Intervention:
38 Recruiting Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy
Condition: Thyroid Associated Opthalmopathies
Interventions: Drug: Prednisone+placebo of Doxycycline;   Drug: Doxycycline+placebo of Prednisone
39 Recruiting Doxycycline Treatment in Mild Graves' Orbitopathy
Conditions: Graves Ophthalmopathy;   Graves Disease;   Eye Diseases;   Thyroid Diseases;   Endocrine System Diseases;   Eye Diseases, Hereditary;   Hyperthyroidism;   Autoimmune Diseases;   Immune System Diseases
Interventions: Drug: Doxycycline;   Drug: placebo
40 Not yet recruiting The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease
Condition: Thyroid Eye Disease
Interventions: Drug: Methylprednisolone + ASTED;   Drug: Methylprednisolone +Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-41) Show next page of results    Last Page
Indicates status has not been verified in more than two years